A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo

A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo

This study is a post-marketing surveillance of Besivo in participants with chronic hepatitis B.

This post-marketing surveillance required by Korea MFDS regulation. The objectives of this study are to monitor adverse events and effectiveness of Besivo.

Inclusion Criteria:

• The patient diagnosed with chronic hepatitis B.
• The patient who is first prescribed and administered Besivo.

Exclusion Criteria:

• The patients who are overreacting to this drug or its components
• Medium to severe Renal function disorder
• The patient under 19
• The Patient who are taboo with L-Carnitine